Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Medpace Holdings
NasdaqGS:MEDP Community
1
Narratives
written by author
0
Comments
on narratives written by author
42
Fair Values set
on narratives written by author
Create a narrative
Medpace Holdings
Popular
Undervalued
Overvalued
Medpace Holdings
AN
Analyst Price Target
Consensus Narrative from 10 Analysts
Productivity Gains And Hiring Boost Will Expand Life Sciences Projects In 2025
Key Takeaways Medpace's hiring plans aim to support project growth and revenue, but may pressure margins if costs outweigh productivity gains. Reducing project cancellations and improving book-to-bill ratios are expected to stabilize and potentially increase revenue flow.
View narrative
US$344.83
FV
6.0% undervalued
intrinsic discount
8.02%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
MEDP
Medpace Holdings
Your Fair Value
US$
Current Price
US$324.23
17.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-16m
3b
2015
2018
2021
2024
2025
2027
2030
Revenue US$3.3b
Earnings US$628.0m
Advanced
Set as Fair Value